Moxisylyte hydrochloride - CAS 964-52-3
Catalog number:
964-52-3
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C16H26ClNO3
Molecular Weight:
315.84
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
Moxisylyte hydrochloride is alpha 1-adrenoceptor antagonist. It can vasodilates cerebral vessels without reducing blood pressure. It is used as peripheral vasodilator. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine. It is used as sympathomimetic agents. It has been listed.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98 %
Appearance:
Off-white Solid
Synonyms:
Carvacrol,5-[2-(dimethylamino)ethoxy]-, acetate (ester), hydrochloride (8CI);Phenol,4-[2-(dimethylamino)ethoxy]-2-methyl-5-(1-methylethyl)-, acetate (ester),hydrochloride (9CI);4-(2-Dimethylaminoethoxy)-5-isopropyl-2-methylphenyl acetatehydrochloride;Opilon hydrochloride;(2-(4-acetoxy-2-isopropyl-5-methylphenoxy)ethyl)dimethylaminehydrochloride;5-(2-(N,N-dimethylamino)ethoxy)carvacrolacetatehydrochloride;Arlitene;Vasoklin;Moxisylyte HCl;[4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] acetate;hydrochloride;Thymoxamine hydrochloride
Solubility:
Soluble in ethanol (50 mg/ml)
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
Moxisylyte hydrochloride is used as peripheral vasodilator. It is also used as sympathomimetic agents.
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Grams to Kilograms
Melting Point:
208-210 °C
InChIKey:
IPWGSXZCDPTDEH-UHFFFAOYSA-N
InChI:
InChI=1S/C16H25NO3.ClH/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6;/h9-11H,7-8H2,1-6H3;1H
Canonical SMILES:
CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C.Cl
Current Developer:
Moxisylyte hydrochloride has been listed.
1.Oral vasodilators for primary Raynaud's phenomenon.
Vinjar B1, Stewart M. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006687. doi: 10.1002/14651858.CD006687.pub2.
BACKGROUND: Many different drugs have been suggested for the symptomatic treatment of primary Raynaud's phenomenon. Apart from calcium channel blockers, which are considered the drugs of choice, the evidence of the effects of alternative pharmacological treatments is limited.
2.Raynaud's phenomenon (primary).
Pope JE1. BMJ Clin Evid. 2008 Dec 16;2008. pii: 1119.
INTRODUCTION: Raynaud's phenomenon is an episodic vasospasm of the peripheral arteries, causing pallor followed by cyanosis and redness with pain and sometimes paraesthesia. On rare occasions it can lead to ulceration of the fingers and toes (and in some cases of the ears or nose). This review focuses on primary (idiopathic) Raynaud's phenomenon occurring in the absence of an underlying disease. The prevalence of primary Raynaud's phenomenon varies by sex, country, and exposure to workplace vibration.
3.Noradrenergic control of GnRH release from the ewe hypothalamus in vitro: sensitivity to oestradiol.
Ghuman SP1, Jones DN, Prabhakar S, Smith RF, Dobson H. Reprod Domest Anim. 2008 Dec;43(6):753-9. doi: 10.1111/j.1439-0531.2007.00997.x. Epub 2008 May 13.
The present study investigates the influence of alpha(1)-adrenoreceptors in GnRH release in vitro and determines whether oestradiol modulates alpha(1)-adrenoreceptor-GnRH interaction. Within 10 min after ewe sacrifice, saggital midline hypothalamic slices were dissected, placed in oxygenated Minimum Essential Media-alpha (MEM-alpha) at 4 degrees C and within 2 h were singly perifused at 37 degrees C with oxygenated MEM-alpha (pH 7.4; flow rate 0.15 ml/min), either with or without oestradiol (24 pg/ml). After 4-h equilibration, 10-min fractions were collected for 4 h interposed with a 10-min exposure at 60 min to specific alpha(1)-adrenoreceptor agonist (methoxamine) or antagonist (thymoxamine) at various doses (0.1-10 mm). The alpha(1)-adrenoreceptor agonist (10 mm) increased (p < 0.05) GnRH release at 90 min both in presence and absence of oestradiol. However, in presence of oestradiol, alpha(1)-adrenoreceptor agonist (10 mm)-induced GnRH release remained elevated (p < 0.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


CAS 51-42-3 Epinephrine Bitartrate

Epinephrine Bitartrate
(CAS: 51-42-3)

Epinephrine Bitartrate is an alpha- and beta-adrenergic receptor stimulator. It can be used for the treatment of asthma and cardiac failure via stimulating the ...

CAS 7683-59-2 isoproterenol

isoproterenol
(CAS: 7683-59-2)

Isoproterenol can be used for the treatment of bradycardia (slow heart rate), heart block, and rarely for asthma. It is a non-selective β adrenoreceptor agonist...

CAS 849-55-8 Nylidrin hydrochloride

Nylidrin hydrochloride
(CAS: 849-55-8)

Nylidrin hydrochloride is a beta-adrenergic agonist. It was an effective inhibitor of IgE-mediated release of histamine from passively sensitized rat peritoneal...

CAS 118457-16-2 (-)-Nebivolol

(-)-Nebivolol
(CAS: 118457-16-2)

This active molecular is a β-adrenergic receptor antagonist. Levonebivolol is an enantiomer of Nebivolol which is a β1 receptor blocker with nitric oxide-potent...

CAS 26921-17-5 Timolol Maleate

Timolol Maleate
(CAS: 26921-17-5)

Timolol Maleate is a non-selective, beta-adrenergic receptor antagonist for β1/β2 with Ki of 1.97 nM/2.0 nM.

CAS 57262-94-9 Setiptiline

Setiptiline
(CAS: 57262-94-9)

Setiptiline is is a serotonin receptor antagonist acts as a noradrenergic and specific serotonergic antidepressant.

Vilanterol trifenatate
(CAS: 503070-58-4)

Vilanterol, also known as GW-642444, is a long-acting beta-2 agonist drug, which in May 2013 was approved in combination with fluticasone furoate for sale as Br...

Fenoterol hydrochloride
(CAS: 1944-10-1)

Fenoterol hydrochloride is a β2 adrenoreceptor agonist used as a bronchodilator for the treatment and prophylaxis of reversible bronchospasm, administered by in...

CAS 104054-27-5 Atipamezole

Atipamezole
(CAS: 104054-27-5)

Atipamezole, a 4-substituted imidazole derivative, is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering ...

CAS 63-92-3 Phenoxybenzamine HCl

Phenoxybenzamine HCl
(CAS: 63-92-3)

Phenoxybenzamine HCl is a non-specific, irreversible alpha antagonist with an IC50 of 550 nM.

CAS 753498-25-8 Indacaterol Maleate

Indacaterol Maleate
(CAS: 753498-25-8)

Indacaterol is an ultra-long-acting β-adrenoceptor agonist with pKi of 7.36.

CAS 43229-80-7 Formoterol Hemifumarate

Formoterol Hemifumarate
(CAS: 43229-80-7)

Formoterol Hemifumarate is a potent, selective and long-acting β2-adrenoceptor agonist to β2 and β1 receptors with pKd of 8.12 and 5.58, respectively.

CAS 67346-49-0 (R,R)-Formoterol

(R,R)-Formoterol
(CAS: 67346-49-0)

(R,R)-Formoterol is a long acting beta-adrenoceptor agonist acts as a novel highly β2-selective adrenergic agonist and holds promise as a β2-agonist that could ...

CAS 81403-80-7 Alfuzosin

Alfuzosin
(CAS: 81403-80-7)

Alfuzosin is a pharmaceutical drug of the alpha-1 blocker class. It works by relaxing the muscles in the prostate and bladder neck. It is used to treat benign p...

CAS 104075-48-1 Atipamezole hydroChloride

Atipamezole hydroChloride
(CAS: 104075-48-1)

The hydrochloride salt form of atipamezole that is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering blo...

CAS 41372-08-1 L-α-Methyl DOPA Hydrate

L-α-Methyl DOPA Hydrate
(CAS: 41372-08-1)

L-α-Methyl DOPA Hydrate is an alpha-adrenergic agonist used as a sympatholytic or antihypertensive.

MK-0634
(CAS: 211031-01-5)

MK-0634, also called as L-796568, is an β3 adrenergic receptor agonist that was progressed into clinical studies for the treatment of obesity in the early 2000s...

CAS 5985-28-4 Synephrine Hydrochloride

Synephrine Hydrochloride
(CAS: 5985-28-4)

SynephrineHCl (Oxedrine, p-Synephrine) is a sympathomimetic α-adrenergic receptor (AR) agonist.

CAS 770-05-8 DL-Octopamine hydrochloride

DL-Octopamine hydrochloride
(CAS: 770-05-8)

Octopamine hydrochloride is an α-adrenoceptor agonist.

CAS 98418-47-4 Metoprolol succinate

Metoprolol succinate
(CAS: 98418-47-4)

Metoprolol succinate is a selective β-adrenoceptor antagonist. It is used in treatment of several diseases of the cardiovascular system. It is a drug used in th...

Chemical Structure

CAS 964-52-3 Moxisylyte hydrochloride

Quick Inquiry

Verification code

Featured Items